G702-6893 Screening compound: 1-benzyl-4-{2-[(4-chlorophenyl)methyl]-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-yl}piperazine

G702-6893 Screening compound: 1-benzyl-4-{2-[(4-chlorophenyl)methyl]-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-yl}piperazine
G702-6893 Screening compound: 1-benzyl-4-{2-[(4-chlorophenyl)methyl]-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-yl}piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound G702-6893
1-benzyl-4-{2-[(4-chlorophenyl)methyl]-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-yl}piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G702-6893

Molecular Formula

C27H29ClN6 (C27 H29 ClN6)

Compound Name

1-benzyl-4-{2-[(4-chlorophenyl)methyl]-5H,6H,7H,8H-[1,2,4]triazolo[3,2-b]quinazolin-9-yl}piperazine

IUPAC name

1-benzyl-4-{2-[(4-chlorophenyl)methyl]-5H6H7H8H-[124]triazolo[32-b]quinazolin-9-yl}piperazine

SMILES

Clc1ccc(Cc2nn3c(N4CCN(Cc5ccccc5)CC4)c(CCCC4)c4nc3n2)cc1

InChI

InChI=1S/C27H29ClN6/c28-22-12-10-20(11-13-22)18-25-30-27-29-24-9-5-4-8-23(24)26(34(27)31-25)33-16-14-32(15-17-33)19-21-6-2-1-3-7-21/h1-3,6-7,10-13H,4-5,8-9,14-19H2

InChI Key

OQFNIWBVXMIRKG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27152185

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

473.02

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.191

Distribution Coefficient, logD

4.792

Water Solubility, LogSw

-5.75

Polar Surface Area

42.949

Acid Dissociation Constant (pKa)

25.54

Base Dissociation Constant (pKb)

7.58

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.00

G702-6893 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GABA Library (7115 compounds)

GPCR Targeted Library (31838 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Eye
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Nervous system
Targets:
  • GPCR
  • Ion Channels
  • GPCR
  • GPCR
  • Ion Channels
Mechanism of action:
  • Receptor's ligands
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G702-6893 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G702-6893?
Check Price and Availability of G702-6893, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G702-6893 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G702-6893
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G702-6893
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G702-6893 available by request